Tuberculous meningitis: Difference between revisions

From IDWiki
()
No edit summary
Line 2: Line 2:
 
* High mortality, often needs empiric treatment even before confirmed diagnosis
 
* High mortality, often needs empiric treatment even before confirmed diagnosis
   
== Classification ==
+
== Background ==
  +
=== Classification ===
 
 
* Stage 1: normal level of consciousness, no focal neurological deficits
 
* Stage 1: normal level of consciousness, no focal neurological deficits
 
* Stage 2: decreased level of counsciousness, significant focal neurological deficits
 
* Stage 2: decreased level of counsciousness, significant focal neurological deficits
 
* Stage 3: seizures, comatose
 
* Stage 3: seizures, comatose
   
== Epidemiology ==
+
=== Epidemiology ===
 
 
* About 1% of TB cases in Canada
 
* About 1% of TB cases in Canada
   
== Differential Diagnosis ==
+
=== Differential Diagnosis ===
 
 
* Fungal meningitis
 
* Fungal meningitis
 
* Sarcoidosis
 
* Sarcoidosis
 
* Neoplasm
 
* Neoplasm
   
== Risk Factors ==
+
=== Risk Factors ===
 
 
* Young
 
* Young
 
* Female
 
* Female
Line 25: Line 22:
 
* Previous TB
 
* Previous TB
   
== Presentation ==
+
== Clinical Presentation ==
 
 
=== History ===
 
=== History ===
   
Line 44: Line 40:
   
 
=== Physical Exam ===
 
=== Physical Exam ===
 
 
* Meningeal symptoms
 
* Meningeal symptoms
 
* Fevers
 
* Fevers
Line 56: Line 51:
   
 
== Investigations ==
 
== Investigations ==
 
 
* Lumbar puncture
 
* Lumbar puncture
 
** Increased lymphocytes, decreased glucose, and increased protein
 
** Increased lymphocytes, decreased glucose, and increased protein
Line 64: Line 58:
   
 
== Management ==
 
== Management ==
 
 
* Rule out neoplasm and fungus, then start empiric treatment
 
* Rule out neoplasm and fungus, then start empiric treatment
 
* HIV test (delay antiretrovirals by 8 weeks, though)
 
* HIV test (delay antiretrovirals by 8 weeks, though)
Line 73: Line 66:
   
 
== Prognosis ==
 
== Prognosis ==
 
 
* Depends on stage at presentation
 
* Depends on stage at presentation
 
* Mortality is high
 
* Mortality is high

Revision as of 20:54, 20 January 2020

Background

Classification

  • Stage 1: normal level of consciousness, no focal neurological deficits
  • Stage 2: decreased level of counsciousness, significant focal neurological deficits
  • Stage 3: seizures, comatose

Epidemiology

  • About 1% of TB cases in Canada

Differential Diagnosis

  • Fungal meningitis
  • Sarcoidosis
  • Neoplasm

Risk Factors

  • Young
  • Female
  • Originally from endemic country
  • Previous TB

Clinical Presentation

History

  • Prodrome (1-3 weeks)
    • Personality changes
    • Low-grade fever
    • Malaise
    • Weight loss
    • Gradual onset of worsening headache
  • Headache
  • Fevers
  • Vomiting
  • Confusion
  • Personality changes
  • Photophobia (only 5-10%)
  • Seizures

Physical Exam

  • Meningeal symptoms
  • Fevers
  • Vomiting
  • Meningismus
  • Focal neurological deficits
    • Cranial nerve palsies in VI, III, and IV
    • Hemiplegia, paraplegia
    • Urinary retention
  • Confusion, coma

Investigations

  • Lumbar puncture
    • Increased lymphocytes, decreased glucose, and increased protein
    • Need 3-5mL of CSF for culture
    • May need serial LPs
  • CT head

Management

  • Rule out neoplasm and fungus, then start empiric treatment
  • HIV test (delay antiretrovirals by 8 weeks, though)
  • Standard HREZ x2mo then HR x7-10mo
    • Can replace ethambutol with a fluoroquinolone
  • Dexamethasone 3mg po qid x2wk then taper over 6-8wks
    • High risk of IRIS

Prognosis

  • Depends on stage at presentation
  • Mortality is high
    • Stage 1: 10-20%
    • Stage 2: 20-40%
    • Stage 3: 60%
  • Morbidity is high, with about 20% of patient being left with significant neurological sequelae
    • Mental retardation
    • Psychiatric disorders
    • Seizures
    • Blindness
    • Deafness
    • Ophthalmoplegia
    • Hemiparesis

References

  1. ^  GE Thwaites, TTH Chau, K Stepniewska, NH Phu, LV Chuong, DX Sinh, NJ White, CM Parry, JJ Farrar. Diagnosis of adult tuberculous meningitis by use of clinical and laboratory features. The Lancet. 2002;360(9342):1287-1292. doi:10.1016/s0140-6736(02)11318-3.